Not long ago, vaccines had largely bipartisan support. But they have become a divisive issue in the U.S., fueled by the COVID-19 pandemic an...

A panel of academics, doctors and patients examined 80 existing treatments to identify those mostly likely to help tackle Alzheimer's - for...

The next ACIP meeting in early December will examine the hepatitis B shot and the childhood vaccine schedule.

Sen. Bill Cassidy (R-La.) on Sunday said he is "very concerned" about the possibility of changing the hepatitis B vaccine schedule for infan...

Scientists are warning that this winter's flu vaccine will be less effective against an emerging variant of H3N2 flu named subclade K.

More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year...

Health Secretary Robert F. Kennedy Jr’s panel of federal vaccine advisors is set to discuss and potentially vote on changing the hepatitis B...

The Supreme Court of India has raised questions over the apparent inconsistency in trust between Covid vaccine data reported by the United K...

Three panelists engaged in a spirited discussion about longevity and disease prevention at a TIME100 Talks event moderated by TIME senior he...

The disease remains a significant cause of illness and death in the region, including Zambia, Zimbabwe, Malawi, Kenya, and Mozambique...

Japan has donated 3 million doses of its LC16 vaccine to Congo to help fight a new form of mpox known as clade Ib, which sparked a global he...

By MOGOMOTSI MAGOMEJOHANNESBURG (AP) — Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestic...

Donald Trump’s wrecking-ball style of politics has been causing chaos in healthcare, just as in other areas of domestic and foreign policy....

By now, you know that the COVID-19 vaccine is the best way to protect against severe COVID infections and reduce your chances of developing...

HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phas...